ABSTRACT
INTRODUCTION
Vascular calcification is common with aging, diabetes and kidney disease and is associated with increased cardiovascular morbidity.
(1)
Mitral annular calcification (MAC) is a fibrous non-inflammatory degenerative calcification of the mitral valve ring.
(2)
It was first described in 1908 by Bonninger in its association with complete heart block. It occurs more often in women and the elderly. MAC has been shown to be associated with atherosclerosis, and is a predictor of cardiovascular events. Risk factors vary in these patient groups, but advanced age and inflammations are commonly associated with increased vascular calcification.
(4)
MAC has been found to play a role in atrial enlargement, left ventricular enlargement, atrial fibrillation, conduction defects, mitral regurgitation, mitral stenosis, hypertrophic cardiomyopathy, and bacterial endocarditis. Until recently, vascular calcification in the context of a mineral imbalance was considered to be an unregulated consequence of the deposition of insoluble basic calciumphosphate (BCP; mixture of octacalcium phosphate, dicalcium phosphate dihyderate, and apatite) mineral in the extracellular matrix occurring when concentration of Ca and Phosphate ions in the local environment/circulation exceeded the solubility product for calcium phosphate.
(6)
Fetuin-A (alpha-2-Heremans Schmid glycoprotein) is produced during fetal development by multiple tissues, whereas in adults it is synthesized predominantly by the liver.
(7) It is a member of the cystatin super-family of cysteine protease inhibitors. Fetuin-A constitutes the largest α2-band in serum electrophoresis. Its normal serum concentration amounts to 0.5 to 1 g/L, and it is down-regulated under conditions of inflammation.
(8) Fetuin-A has recently been described as a serum-based inhibitor of calcification.
(9)
In vitro studies demonstrate that fetuin-A forms a complex with calcium and phosphorus and increases their solubility in a manner reminiscent of the mean by which apolipoproteins solubilize lipids.
(10)
Among persons with end-stage renal disease, lower fetuin-A concentrations are associated with more extensive vascular calcification in cross-sectional analyses and with increased cardiovascular events and all-cause mortality longitudinally. (11,12) Besides playing a pivotal role in the inhibition of Ca x P precipitation, fetuin-A exhibits additional antiinflammatory and phagocytosispromoting activity.
(8) Nearly few is known about fetuin-A serum levels in non renal patients with mitral annular calcification.
(13)
The aim of the present study was designed to evaluate the predictive value of serum fetuin-A concentration and mitral annular calcification (MAC) in patients with suspected/diagnosed coronary artery disease. Mitral annular calcification was defined by an echodense structure located at the junction of the atrio ventricular groove and the posterior mitral leaflet on the parasternal long-axis, apical 4-chamber or parasternal short axis views. 
SUBJECTS & METHODS

Coronary Angiography
The presence of coronary artery disease was determined by coronary angiography, cardiologist trained in coronary angiography and unaware of the echocardiogrpahic results operated and interpreted the angiographic studies visually, significant coronary artery disease was defined as any stenosis of >70% in at least one major epicardial coronary artery or >50% in the left main coronary artery. 
Distal left main coronary artery stenosis
Triple vessels coronary artery stenosis
Biochemical investigation:
Kidney function was determined by estimated glomerular filtration rate=186x (serum creatinine Fasting 12 hours blood sample were obtained and serum separated by centrifugation (850-1500Xg for 10 min.). Serum samples were stored frozen at -20 0 C, to measure Fetuin-A, cardiophase hsCRP, calcium, phosphorus, total cholesterol, highdensity lipoprotein cholesterol, and triglyceride levels using Daimension RXL Max clinical chemistry system (Dade Behring USA) . Low-density lipoprotein cholesterol concentrations were estimated by the Friedewald equation. 
Cardiophase hsCRP:
Cardiophase hsCRP is an in vitro diagnostic reagent for the quantitative determination of C-reactive protein in human serum by means of particle enhanced immunonephlometery using BNIII system (Dade Behring, USA). The principle of the method; polystyrene particles coated with monocolonal antibodies specific to human CRP are aggregated when mixed with samples containing CRP. These aggregates scatter a beam of light passed through the sample. The intensity of the scattered light is proportional to the concentration of the relevant protein in the sample. The result is evaluated by comparison with a standard of known . Serum Calcium:
The method is modification of the calcium O-cresolphethalien complexone (OCPC) reaction. 
RESULTS
Fifty four patients with suspected/ diagnosed CAD were enrolled in the present study. Patients were divided into 3 groups according to fetuin-A values (low<0.59g/l, within normal 0.6-0.9g/l and high >0.95g/l). There was no intergroup difference as regards age and gender; the mean age was 51+ 3 years age. The gender in groups 1, 2, and 3 were (50% male, 50% female, 41.6% male, 58.4% female and 40% male, 60%female respectively). There was no statistical significant difference among studied groups regarding to past history of risk factors such as, diabetes mellitus, hypertension, as well as history of coronary artery disease (P>0.05) clearance, calcium and phosphorus showed non significant difference between all groups (P>0.05). When we studied correlation between studied parameters and fetuin-A value among all patients, there were highly significant negative correlation between fetuin-A and hsCRP (r= -0.717 P<0.01). Significant negative correlation between fetuin-A and LDL-c, while cholesterol, calcium, phosphorus, creatinine clearance showed statistically non significant correlation (P>0.05).
After multivariate logistic regression analysis table(5), MAC and fetuin-A were found to be the main independent predictors for the presence of significant coronary artery disease; significance for MAC was 0.0001, and fetuin-A was 0.0019, while dyslipidemia, diabetes mellitus and age were non-significant.
The prevalence of coronary artery disease after cardiac catheterization among different studied group with different levels of fetuin-A were shown in figure (4). We found significantly higher incidence of obstructive coronary artery disease among patients with low fetuin-A in comparison to other groups. The prevalence percentage was (37%, 7%, 9%) in groups 1,2,3 respectively. 
DISCUSSION
The serum fetuin-A is a potent systemic inhibitor of soft tissue calcification, fetuin-A is highly effective in the formation and stabilization of protein-mineral colloid, referred to as calciprotein particles (CPP). Albumin and acidic protein in general greatly enhanced the fetuin-A triggered formation of secondary CPPs and this substituted substantial amounts of fetuin-A without loss of inhibition of calcium phosphate precipitation. Nearly few is known about fetuin-A serum level in non renal patients.
(13)
Mitral annular calcification is a fibrous, degenerative calcification of the mitral valve support ring and it has been shown to be associated with atherosclerosis.
(25) A prior prospective investigation from the Framingham heart study, MAC was independently associated with stroke.
(15) and cardiovascular events. Experimentally induced systemic arterial atherosclerosis is associated with the deposition of fatty plaques on the ventricular surface of the posterior mitral leaflet.
(27) These findings suggest that coronary atherosclerosis and MAC have a similar etiology.
Here in the present study we evaluate the serum fetuin-A concentration and mitral annular calcification as a predictors for significant coronary artery disease in patients with suspected/diagnosed coronary artery disease (with no renal impairment). Importantly the current studied groups were matched regarding age, gender and clinical history of diabetes and hypertension in order to element any errors during evaluation of MAC and fetuin -A as predictors for significant CAD.
One of the main results of the present study was that we demonstrate an inverse association of serum fetuin-A concentration with MAC among those patients either suspected /diagnosed CAD. Also, a strong association was observed between low fetuin-A level and prevalence of significant CAD. These finding are consistent to some degree with the results of Ix et al. (2007) (11) who stated that fetuin-A may represent an important inhibitor of dystrophic calcification in persons with coronary artery disease.
In the present study we find that fetuin-A is inversely correlated with hs-CRP in all studied groups. These findings are consistent with results found by Kuznair et al.
(9) and Ix et al.
( As regard to the prseent Echocardiographic findings, the group of patients with MAC and low fetuin-A level had the lowest EF% in comparison to other groups , as well as the incidence of resting RWMAs was higher in same group indicating a significant myocardial ischemia in those patients , these findings were in agreement with previous studies. Boon and his colleagues (30) found an association of MAC with age and vascular risk factors (age, female sex, hypertension, diabetes mellitus and hypercholesterolemia).
Thus, a significant association of MAC with known major risk factors for CAD may partly explain the association of MAC with obstructive CAD on angiography in the present study.
One of the main finding of the current study is that mitral annular calcification is an independent predictor of the presence of severe stenosis (> 70% diameter stenosis) in at least one major epicardial coronary artery in patients presenting with chest pain. Moreover, mitral annular calcification is an indicator of a higher prevalence of triple vessel disease or significant left main coronary artery stenosis in our patients groups especially when associated with low fetuin-A level.
Angiographic finding in the present study were similar to those reported by Atar and his colleagues (15) , both studies showed that MAC is a marker and dependent predictor for presence of significant CAD, where our study showed that patients group with MAC owing a great prevalence of LM & TVD coronary lesions in comparison to those patients with no MAC.
Therefore, we considered that, the unique finding of our study was the triple arms results of association between the presence of mitral annular calcification , low fetuin-A level and significant coronary artery disease .
Conclusion and clinical implications
The detection of mitral annular calcification by simple non invasive imaging method as transthoracic echocardiolgraphy in association with low fetuin-A level, may be considered as independent predictors for the presence of significant obstructive coronary artery disease. Therefore, in symptomatic patients with suspected CAD, the presence of MAC and low fetuin-A level may support the need for an invasive evaluation of the patient's complaints with aggressive modification of risk factors. 
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